Cancer Center News

Children’s Hospital of Philadelphia (CHOP) announced nearly $2 million in funding from the V Foundation for Cancer Research, a nonprofit that supports peer-reviewed cancer research. The grants were awarded to two research leaders advancing innovative approaches to detecting and treating cancer in children. Andrei Thomas-Tikhonenko, PhD, Chief of the Division of Cancer Pathobiology at CHOP, was awarded the $1 million V Foundation Pediatric All-Star Cancer Research Grant to develop a novel chimeric antigen receptor (CAR) T-cell therapy for children with T-cell acute lymphoblastic leukemia (T-ALL), an aggressive form of blood cancer.

In this recent Q&A, Dr. Timothy Olson discusses the Blood and Marrow Transplant Program’s half century of care at CHOP, his clinical and research goals, and more.

The Award recognizes members of the NF community whose lifelong contributions have advanced NF research or clinical care.

Colleen Callahan, RN, MSN, CRNP, a Nurse Practitioner on the Cancer Immunotherapy team in the Cancer Center at Children’s Hospital of Philadelphia, is this year’s recipient of the Alex’s Lemonade Stand Pitcher of Hope Award.

A new CRISPR-based tool that is directly used on patients’ cancer cells can identify genes and regulatory elements driving AML. This first-of-its-kind approach reveals how individual patient cells respond to genetic changes and makes it easier to identify drug targets and understand why some cancers stop responding to treatment.

D3B is among several institutions that will help scale a national pediatric data and knowledge network to improve health outcomes for children with complex diseases, beginning with pediatric brain cancer.

This case study showcases how multidisciplinary evaluation and intraoperative pathology at CHOP enabled management of a rare paratesticular tumor.

Two new CHOP Cancer Center case reports show that picking the right genetic test matters – using the wrong assay can miss actionable alterations and change treatment options.

Children’s Hospital of Philadelphia is pleased to announce that four of its Cancer Center clinicians and researchers were awarded $1.8 million in research grants from Braden’s Hope for Childhood Cancer, a Kansas City-based nonprofit that funds cutting-edge pediatric cancer research and raises community awareness.

Researchers at Children’s Hospital of Philadelphia (CHOP) identified promising methods to enhance the effectiveness of chimeric antigen receptor (CAR) T cell therapy in neuroblastoma, a deadly pediatric cancer.